Brambs C - Search Results

1

Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer.

Hoffmann OI, Regenauer M, Czogalla B, Brambs C, Burges A, Mayer B. Hoffmann OI, et al. Among authors: brambs c. Cancers (Basel). 2022 May 3;14(9):2279. doi: 10.3390/cancers14092279. Cancers (Basel). 2022. PMID: 35565408 Free PMC article.

2

What is the evidence for lymphadenectomy in presumed early ovarian cancer?

Schmalfeldt B, Brambs C, Burges A, El-Balat A, Emons G, Fink D, Fotopoulou C, Gropp-Meier M, Hanker LC, Harter P, Hasenburg A, Hauptmann S, Hilpert F, Kimmig R, Kommoss S, Kurzeder C, Mahner S, Marmé F, Mayr D, Meier W, Meinhold-Heerlein I, Mustea A, Ortmann O, Oskay-Özcelik G, Pfisterer J, Pölcher M, Runnebaum IB, Schröder W, Tanner B, Wagner U, Wimberger P, Sehouli J. Schmalfeldt B, et al. Among authors: brambs c. Arch Gynecol Obstet. 2019 Jan;299(1):1-5. doi: 10.1007/s00404-018-4945-8. Arch Gynecol Obstet. 2019. PMID: 30374648 No abstract available.

3

Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer.

Dötzer K, Schlüter F, Koch FEV, Brambs CE, Anthuber S, Frangini S, Czogalla B, Burges A, Werner J, Mahner S, Mayer B. Dötzer K, et al. Biomedicines. 2021 Mar 12;9(3):289. doi: 10.3390/biomedicines9030289. Biomedicines. 2021. PMID: 33809043 Free PMC article.

4

Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer.

Czogalla B, Dötzer K, Sigrüner N, von Koch FE, Brambs CE, Anthuber S, Frangini S, Burges A, Werner J, Mahner S, Mayer B. Czogalla B, et al. Biomedicines. 2022 Oct 25;10(11):2694. doi: 10.3390/biomedicines10112694. Biomedicines. 2022. PMID: 36359213 Free PMC article.

5

Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients.

Stögbauer F, Geß B, Brambs C, Lautizi M, Kacprowski T, Ourailidis I, Bronger H, Kiechle M, Noske A, Keller G, Jesinghaus M, Poremba C, Weichert W, Boxberg M. Stögbauer F, et al. Among authors: brambs c. Cancers (Basel). 2023 Jul 28;15(15):3832. doi: 10.3390/cancers15153832. Cancers (Basel). 2023. PMID: 37568650 Free PMC article.

6

NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer.

Konrad SM, Schwamborn K, Krüger A, Honert K, Schmitt M, Hellmann D, Schmalfeldt B, Meindl A, Kiechle M, Quante AS, Brambs C, Grill S, Ramser J. Konrad SM, et al. Among authors: brambs c. Biomark Med. 2022 Oct;16(14):1029-1041. doi: 10.2217/bmm-2021-0781. Epub 2022 Nov 29. Biomark Med. 2022. PMID: 36444691

7

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.

Grill S, Ramser J, Hellebrand H, Pfarr N, Boxberg M, Brambs C, Ditsch N, Meindl A, Groß E, Meitinger T, Kiechle M, Quante AS. Grill S, et al. Among authors: brambs c. Arch Gynecol Obstet. 2021 Jun;303(6):1557-1567. doi: 10.1007/s00404-020-05883-x. Epub 2020 Nov 27. Arch Gynecol Obstet. 2021. PMID: 33245408 Free PMC article.

8

Incidence and predictors for chemotherapy modifications and their impact on the outcome of ovarian cancer patients.

Hatsy S, Brambs C, Kiechle M. Hatsy S, et al. Among authors: brambs c. Arch Gynecol Obstet. 2023 Jun;307(6):1891-1899. doi: 10.1007/s00404-022-06813-9. Epub 2022 Nov 3. Arch Gynecol Obstet. 2023. PMID: 36326848 Free PMC article.

9

Sentinel lymph node mapping with indocyanine green compared to blue dye tracer in gynecologic malignancies-A single center experience of 218 patients.

Pölcher M, Matz S, Braun M, Brambs C, Beer M, Hamann M. Pölcher M, et al. Among authors: brambs c. J Surg Oncol. 2021 Mar;123(4):1092-1098. doi: 10.1002/jso.26338. Epub 2020 Dec 17. J Surg Oncol. 2021. PMID: 33333589 Clinical Trial.

10

Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany.

Grimm D, Mathes S, Woelber L, Van Aken C, Schmalfeldt B, Mueller V, Kiechle M, Brambs C, Paepke D. Grimm D, et al. Among authors: brambs c. Arch Gynecol Obstet. 2021 May;303(5):1315-1330. doi: 10.1007/s00404-020-05880-0. Epub 2020 Dec 2. Arch Gynecol Obstet. 2021. PMID: 33263787 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page